Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial

Trial ID or NCT#

NCT04672655

Status

recruiting iconRECRUITING

Purpose

This study is a comprehensive, multicomponent behavioral intervention package (ONBOARD; OvercomiNg Barriers & Obstacles to Adopting Diabetes Devices). ONBOARD will provide adults with T1D the skills to maximize benefit and minimize daily interference from barriers associated with Continuous Glucose Monitoring (CGM) and increase readiness for closed loop.

Official Title

Overcoming Barriers and Obstacles to Adopting Diabetes Devices (ONBOARD) Trial

Eligibility Criteria

Ages Eligible for Study: 18 Years to 50 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No
Inclusion Criteria:
  1. 1. Subject is age 18-50 years at time of enrollment 2. Subject must not have been using CGM regularly for past 6 months 3. Subject has a clinical diagnosis of type 1 diabetes 4. Subject comprehends spoken and written English
Exclusion Criteria:
  1. 1. Subject has a medical disorder that in the judgment of the investigator will interfere with completion of any aspect of the protocol. 2. Subject has a neurologic disorder that in the judgment of the investigator will affect completion of the protocol.

Investigator(s)

Molly Tanenbaum
Clinical Assistant Professor, Medicine - Endocrinology, Gerontology, & Metabolism Clinical Assistant Professor (By courtesy), Pediatrics - Endocrinology and Diabetes
Marina Basina
Marina Basina
Endocrinologist
Clinical Professor, Medicine - Endocrinology, Gerontology, & Metabolism

Contact us to find out if this trial is right for you.

Contact

Molly Tanenbaum, PhD
650-725-3955